These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2012352)

  • 1. In-vitro assessment of a hypersensitivity syndrome associated with sorbinil.
    Spielberg SP; Shear NH; Cannon M; Hutson NJ; Gunderson K
    Ann Intern Med; 1991 May; 114(9):720-4. PubMed ID: 2012352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.
    Riley RJ; Maggs JL; Lambert C; Kitteringham NR; Park BK
    Br J Clin Pharmacol; 1988 Nov; 26(5):577-88. PubMed ID: 3207562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-protein conjugates--XVI. Studies of sorbinil metabolism: formation of 2-hydroxysorbinil and unstable protein conjugates.
    Maggs JL; Park BK
    Biochem Pharmacol; 1988 Feb; 37(4):743-8. PubMed ID: 3342105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose reductase inhibitors in clinical practice. Preliminary studies on diabetic neuropathy and retinopathy.
    Pitts NE; Gundersen K; Mehta DJ; Vreeland F; Shaw GL; Peterson MJ; Collier J
    Drugs; 1986; 32 Suppl 2():30-5. PubMed ID: 3098543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial occurrence of hypersensitivity to phenytoin.
    Gennis MA; Vemuri R; Burns EA; Hill JV; Miller MA; Spielberg SP
    Am J Med; 1991 Dec; 91(6):631-4. PubMed ID: 1750433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase inhibitors and late complications of diabetes.
    Benfield P
    Drugs; 1986; 32 Suppl 2():43-55. PubMed ID: 3098544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of an aldose reductase inhibitor (Sorbinil) on the level of metabolites in lenses of diabetic rats.
    Gonzalez AM; Sochor M; McLean P
    Diabetes; 1983 May; 32(5):482-5. PubMed ID: 6404681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sorbinil on blood-retinal barrier in early diabetic retinopathy.
    Cunha-Vaz JG; Mota CC; Leite EC; Abreu JR; Ruas MA
    Diabetes; 1986 May; 35(5):574-8. PubMed ID: 3514333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sorbinil treatment on erythrocytes and platelets of persons with diabetes.
    Martyn CN; Matthews DM; Popp-Snijders C; Tucker J; Ewing DJ; Clarke BF
    Diabetes Care; 1986; 9(1):36-9. PubMed ID: 3948646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cone electroretinograms and visual acuities of diabetic patients on sorbinil treatment.
    Biersdorf WR; Malone JI; Pavan PR; Lowitt S
    Doc Ophthalmol; 1988 Jul; 69(3):247-54. PubMed ID: 3168726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predisposition to phenytoin hepatotoxicity assessed in vitro.
    Spielberg SP; Gordon GB; Blake DA; Goldstein DA; Herlong HF
    N Engl J Med; 1981 Sep; 305(13):722-7. PubMed ID: 6790991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy.
    Young RJ; Ewing DJ; Clarke BF
    Diabetes; 1983 Oct; 32(10):938-42. PubMed ID: 6225686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sorbinil retinopathy trial: neuropathy results. Sorbinil Retinopathy Trial Research Group.
    Neurology; 1993 Jun; 43(6):1141-9. PubMed ID: 8170559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR; Moriarty RJ; Mayer JH
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats.
    Mauer SM; Steffes MW; Azar S; Brown DM
    Diabetes; 1989 Jul; 38(7):839-46. PubMed ID: 2525493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sorbinil trap: a predicted dead-end complex confirms the mechanism of aldose reductase inhibition.
    Bohren KM; Grimshaw CE
    Biochemistry; 2000 Aug; 39(32):9967-74. PubMed ID: 10933817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
    Beyer-Mears A; Diecke FP; Mistry K; Cruz E
    Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorbinil, an Aldose Reductase Inhibitor, in Fighting Against Diabetic Complications.
    Huang Q; Liu Q; Ouyang D
    Med Chem; 2019; 15(1):3-7. PubMed ID: 29792152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro.
    Gerson WT; Fine DG; Spielberg SP; Sensenbrenner LL
    Blood; 1983 May; 61(5):889-93. PubMed ID: 6831050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.
    Shear NH; Spielberg SP
    J Clin Invest; 1988 Dec; 82(6):1826-32. PubMed ID: 3198757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.